Colorectal Cancer Metastatic Clinical Trials in Guangzhou, Guangdong
5 recruitingGuangzhou, Guangdong, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Phase 1Phase 2
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Colorectal Cancer Metastatic
Sun Yat-sen University64 enrolled1 locationNCT07012954
Recruiting
Phase 2
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Colorectal Cancer Metastatic
Sun Yat-sen University194 enrolled1 locationNCT05727163
Recruiting
Phase 2
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Colorectal Cancer Metastatic
Sun Yat-sen University34 enrolled1 locationNCT06547203
Recruiting
Phase 2
Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study
Colorectal Cancer Metastatic
Sun Yat-sen University64 enrolled1 locationNCT06018714